Nicotinyl methylamide

Nicotinyl methylamide
Names
	Preferred IUPAC name N-Methylpyridine-3-carboxamide
	Other names N-Methylnicotinamide; N-Methylniacinamide
Identifiers
CAS Number	114-33-0 ;
3D model (JSmol)	Interactive image;
Abbreviations	NAN[citation needed]
ChEBI	CHEBI:64399 ;
ChemSpider	58476 ;
DrugBank	DB08840;
ECHA InfoCard	100.003.679
EC Number	204-046-4;
MeSH	C008472
PubChem CID	64950;
UNII	X3I82S5L8I ;
CompTox Dashboard (EPA)	DTXSID00870467 ;
	InChI InChI=1S/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10) Key: ZYVXHFWBYUDDBM-UHFFFAOYSA-N ; InChI=1/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10) Key: ZYVXHFWBYUDDBM-UHFFFAOYAC;
	SMILES CNC(=O)C1=CN=CC=C1;
Properties
Chemical formula	C7H8N2O
Molar mass	136.154 g·mol−1
Pharmacology
ATC code	A05AB01 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Nicotinyl methylamide is an experimental drug with no approved indication.^[1] It is also a metabolite of nicotinamide (vitamin B₃) and is found in urine.^[2]

References

^ "N-methylnicotinamide". DrugBank.
^ "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it.

[1] "N-methylnicotinamide". DrugBank.

[2] "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.

[1]

[2]

v t e Bile and liver therapy (A05)
Bile therapy	bile acid Chenodeoxycholic acid Cholic acid Obeticholic acid Ursodeoxycholic acid Ursodoxicoltaurine Cyclobutyrol Elafibranor Hymecromone Maralixibat chloride Menbutone Nicotinyl methylamide Odevixibat Piprozolin Seladelpar
Liver therapy	Arginine glutamate Citiolone Epomediol Glycyrrhizin Metadoxine Methionine Ornithine oxoglutarate Phospholipids Resmetirom Silymarin Tidiacic arginine

See also

References